BIOMAT Database Logo BIOMAT Database Logo

Bone marrow transplantation in patients with Fanconi anemia: experience with cyclophosphamide and total body irradiation conditioning regimen. 1997

H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Department of Oncology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Eleven patients with Fanconi anemia (FA) underwent bone marrow transplantation (BMT) between March 1985 and May 1990 in a single institution. Ten patients received bone marrow from healthy full human leukocyte antigen (HLA) matched siblings and one patient from her father (one antigen mismatch). Ten patients were conditioned with cyclophosphamide (Cy) at a dose of 5 mg/kg per day for 4 days followed by total body irradiation (TBI) for a total of 600 cGy over 3 days. Six of the 11 patients are alive and have normal reconstitution of their bone marrow. Median follow-up was 72 months (range 42-84). Three of the 10 patients who received Cy and TBI (two HLA compatible, one antigen mismatch) had graft failure. Five patients developed at least grade III acute graft-versus-host disease (GVHD). The rates of graft failure and GVHD are, however, still significantly high. Modification of the conditioning regimen and GVHD prophylaxis is needed to improve the outcome.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D005199 Fanconi Anemia Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id Anemia, Fanconi,Fanconi Hypoplastic Anemia,Fanconi Pancytopenia,Fanconi Panmyelopathy,Fanconi's Anemia,Anemia, Fanconi's,Anemias, Fanconi,Fanconi Anemias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Bone marrow transplantation for patients with Fanconi anemia: reduced doses of cyclophosphamide without irradiation as conditioning.
October 1999, Bone marrow transplantation,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Fertility after bone marrow transplantation following conditioning with cyclophosphamide and total body irradiation.
March 1995, Bone marrow transplantation,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Cytosine arabinoside, cyclophosphamide and total body irradiation conditioning regimens for bone marrow transplantation.
May 1985, East African medical journal,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia.
September 1983, Blood,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
January 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Bone marrow transplantation for severe aplastic anemia in children: conditioning with cyclophosphamide and total lymphoid irradiation.
January 1989, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Bone marrow grafting in aplastic anemia after conditioning with cyclophosphamide and total body irradiation with lung shielding.
January 1980, Haematology and blood transfusion,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
[Unrelated bone marrow transplantation in two severe aplastic anemia patients preconditioned with a regimen of cyclophosphamide, antithymocyte globulin, and total body irradiation].
March 1999, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Bone marrow transplantation for Fanconi anemia using low-dose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction.
October 1993, Blood,
H Solh, and K Rao, and A M Martins da Cunha, and A Padmos, and K Sackey, and P Ernst, and D Spence, and H Clink
Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
March 2007, Pediatric transplantation,
Copied contents to your clipboard!